MALAT1 and lung carcinoma: MALAT1 regulates cisplatin-sensitivity in lung cancer cells by sequestering miR-101-3p from binding to 3′-UTR of MCL1. Therefore, the MALAT1/miR-101-3p/MCL1 signaling cascade plays a major role in cisplatin resistance in lung cancer.